Diagnos Laboratorium Utama Stock Fundamentals
| DGNS Stock | IDR 220.00 4.00 1.79% |
Diagnos Laboratorium Utama fundamentals help investors to digest information that contributes to Diagnos Laboratorium's financial success or failures. It also enables traders to predict the movement of Diagnos Stock. The fundamental analysis module provides a way to measure Diagnos Laboratorium's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Diagnos Laboratorium stock.
Diagnos |
Diagnos Laboratorium Utama Company Operating Margin Analysis
Diagnos Laboratorium's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Diagnos Laboratorium Operating Margin | 0.06 % |
Most of Diagnos Laboratorium's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Diagnos Laboratorium Utama is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Diagnos Laboratorium Utama has an Operating Margin of 0.0589%. This is 100.17% lower than that of the Healthcare sector and 100.09% lower than that of the Diagnostics & Research industry. The operating margin for all Indonesia stocks is 101.07% lower than that of the firm.
Diagnos Laboratorium Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Diagnos Laboratorium's current stock value. Our valuation model uses many indicators to compare Diagnos Laboratorium value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Diagnos Laboratorium competition to find correlations between indicators driving Diagnos Laboratorium's intrinsic value. More Info.Diagnos Laboratorium Utama is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.49 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Diagnos Laboratorium Utama is roughly 2.03 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Diagnos Laboratorium's earnings, one of the primary drivers of an investment's value.Diagnos Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Diagnos Laboratorium's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Diagnos Laboratorium could also be used in its relative valuation, which is a method of valuing Diagnos Laboratorium by comparing valuation metrics of similar companies.Diagnos Laboratorium is currently under evaluation in operating margin category among its peers.
Diagnos Fundamentals
| Return On Equity | 0.0603 | |||
| Return On Asset | 0.0297 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 967.86 B | |||
| Shares Outstanding | 1.25 B | |||
| Shares Owned By Insiders | 80.00 % | |||
| Price To Earning | 10.49 X | |||
| Price To Sales | 1.60 X | |||
| Revenue | 302.18 B | |||
| Gross Profit | 148.56 B | |||
| EBITDA | 19.21 B | |||
| Net Income | 64.3 B | |||
| Cash And Equivalents | 52.8 B | |||
| Cash Per Share | 42.24 X | |||
| Total Debt | 10.45 B | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 7.26 X | |||
| Book Value Per Share | 171.17 X | |||
| Cash Flow From Operations | 58.87 B | |||
| Earnings Per Share | 51.84 X | |||
| Number Of Employees | 568 | |||
| Beta | 0.89 | |||
| Market Capitalization | 302.5 B | |||
| Total Asset | 241.98 B | |||
| Z Score | 17.8 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 241.98 B |
About Diagnos Laboratorium Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Diagnos Laboratorium Utama's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Diagnos Laboratorium using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Diagnos Laboratorium Utama based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.PT Diagnos Laboratorium Utama Tbk provides health services using laboratories. The company was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia. Diagnos Laboratorium operates under Diagnostics Research classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 406 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Diagnos Stock
Diagnos Laboratorium financial ratios help investors to determine whether Diagnos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Diagnos with respect to the benefits of owning Diagnos Laboratorium security.